Skip to content

Clinical trials

Phase 1 Brain Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Diseases Phase: Phase 1 Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20081
20091
20101
20113
20121
20131
20161
20172
20181
20191
20212
20221
20232
20245

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting5
Terminated4
Unknown status3
Withdrawn3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center2
Siena Biotech S.p.A.2
AbbVie (prior sponsor, Abbott)1
Alzheimer's Disease Expert Lab (ADEL), Inc.1
Centre for Addiction and Mental Health1
Cerevel Therapeutics, LLC1
China Medical University Hospital1
Columbia University1
Eli Lilly and Company1
LeonaBio1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Diseases25
Central Nervous System Diseases15
Nervous System Diseases11
Neurodegenerative Diseases10
Alzheimer Disease7
Dementia7
Mental Disorders7
Movement Disorders5
Neurocognitive Disorders5
Brain Neoplasms4

Trials

Showing 76 to 25 of 25. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.